Equities

Ion Beam Applications SA

Ion Beam Applications SA

Actions
Health CareMedical Equipment and Services
  • Price (EUR)13.78
  • Today's Change0.04 / 0.29%
  • Shares traded5.05k
  • 1 Year change+24.14%
  • Beta0.9610
Data delayed at least 15 minutes, as of Nov 25 2024 14:41 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in EURIncome statement in EURView more

Year on year Ion Beam Applications SA had net income fall from a gain of 6.06m to a loss of 9.11m despite a 18.67% increase in revenues from 361.27m to 428.72m. An increase in the cost of goods sold as a percentage of sales from 64.91% to 68.64% was a component in the falling net income despite rising revenues.
Gross margin34.19%
Net profit margin1.69%
Operating margin4.91%
Return on assets1.30%
Return on equity8.86%
Return on investment6.01%
More ▼

Cash flow in EURView more

In 2023, cash reserves at Ion Beam Applications SA fell by 49.06m. Cash Flow from Investing was negative at 13.32m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 19.77m for operations while cash used for financing totalled 14.38m.
Cash flow per share0.6731
Price/Cash flow per share21.22
Book value per share3.09
Tangible book value per share2.22
More ▼

Balance sheet in EURView more

Ion Beam Applications SA has a Debt to Total Capital ratio of 39.92%, a higher figure than the previous year's 36.85%.
Current ratio0.9616
Quick ratio0.6372
Total debt/total equity0.6644
Total debt/total capital0.3992
More ▼

Growth rates in EUR

Year on year, both dividends per share and earnings per share excluding extraordinary items growth dropped -19.05% and -251.93%, respectively.
Div yield(5 year avg)0.88%
Div growth rate (5 year)--
Payout ratio (TTM)78.03%
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago
139.85
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.